Reuters logo
BRIEF-Pacira says phase 4 study shows its drug reduces opioid consumption and postsurgical pain in patients undergoing total knee arthroplasty
March 14, 2017 / 11:43 AM / 6 months ago

BRIEF-Pacira says phase 4 study shows its drug reduces opioid consumption and postsurgical pain in patients undergoing total knee arthroplasty

March 14 (Reuters) - Pacira Pharmaceuticals Inc-

* Phase 4 study shows exparel versus active comparator reduces opioid consumption and postsurgical pain in patients undergoing total knee arthroplasty

* Pacira Pharmaceuticals Inc says also achieved statistical significance for certain key secondary endpoints Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below